|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) through any online brokerage.
The latest price target for Crinetics Pharmaceuticals (NASDAQ: CRNX) was reported by Evercore ISI Group on November 23, 2021. The analyst firm set a price target for 68.00 expecting CRNX to rise to within 12 months (a possible 178.69% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $24.4 last updated Fri Nov 26 2021 18:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals’s $Q3 earnings are confirmed for after-market on November 5, 2021.
There is no upcoming split for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.